CRH
230 hedge funds and large institutions have $1.34B invested in CRH in 2022 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 71 increasing their positions, 78 reducing their positions, and 23 closing their positions.
9,044% more call options, than puts
Call options by funds: $15.5M | Put options by funds: $169K
70% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 23
6% more funds holding
Funds holding: 218 → 230 (+12)
0.47% more ownership
Funds ownership: 4.58% → 5.05% (+0.47%)
9% less repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 78
5% less capital invested
Capital invested by funds: $1.41B → $1.34B (-$70.9M)
Top Buyers
| 1 |
Boston Partners
Boston,
Massachusetts
|
+$54.5M |
| 2 |
Morgan Stanley
New York
|
+$33.7M |
| 3 |
GA
Greenhaven Associates
Purchase,
New York
|
+$29.3M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$27.9M |
| 5 |
CCMG
Clark Capital Management Group
Philadelphia,
Pennsylvania
|
+$17.9M |
Top Sellers
CRH Hedge Fund Activity: Q2 2022 in Review
230 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in CRH (CRH) for Q2 2022, worth a combined $1.34B — down 5% from $1.41B a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new CRH positions and 23 closed out — a net gain of 16 holders — while 71 added to existing stakes and 78 trimmed.
The largest buyer was Boston Partners, adding an estimated $54.5M. The largest seller was Grantham, Mayo, Van Otterloo & Co (GMO), cutting an estimated $15.2M.
- 230 institutional investors held CRH (CRH) as of Q2 2022, up from 218 in Q1 2022.
- Funds reported $1.34B of CRH stock for Q2 2022, down 5% quarter-over-quarter.
- 39 funds opened new CRH positions in Q2 2022 and 23 closed out, a net change of +16 holders.
- The largest CRH buyer in Q2 2022 was Boston Partners, an estimated $54.5M added.
- The largest CRH seller in Q2 2022 was Grantham, Mayo, Van Otterloo & Co (GMO), an estimated $15.2M sold.
Based on aggregated 13F filings for Q2 2022.